Brief: Cochlear Says Co Receives FDA Approval For New Nucleus Nexa System
08/07/2025 01:36
July 8 (Reuters) - Cochlear COH.AX: COCHLEAR RECEIVES FDA APPROVAL FOR NEW NUCLEUS NEXA SYSTEM Further company coverage: COH.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cochlear
See all newsAustralia's Cochlear set for worst week in more than five months
Australia's Cochlear hit with shareholder lawsuit over 2026 earnings forecast (updated)
Australia's Cochlear falls after shareholder class action over FY2026 profit forecast
Cochlear to defend shareholder class action over 2026 profit forecast
Brief: Cochlear says class action claim filed against it in Supreme Court of Victoria